Showing results (181-190 of 196) with videos related to
Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry Letters|April 27, 2007
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonistsJianhua Chao, Arthur G Taveras, Jianping Chao, et al.Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Steroidal C-21 heteroaryl thioethers. Part 3: pregn-4-eno-[3,2-c]pyrazole fused A ring modified steroids as selective glucocorticoid receptor modulators (dissociated steroids)Purakkattle Biju, Hongwu Wang, John Anthes, et al.Cellular and Molecular Neurobiology|November 6, 2021
Loss of SORCS2 is Associated with Neuronal DNA Double-Strand BreaksKaterina O Gospodinova, Ditte Olsen, Mathias Kaas, et al.Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Steroidal C-21 heteroaryl thioethers (Part 2): discovery of orally bioavailable selective glucocorticoid receptor modulators (dissociated steroids)Purakkattle Biju, Kevin McCormick, Robert Aslanian, et al.Cell Reports. Medicine|September 9, 2020
Microbiota Supplementation with Bifidobacterium and Lactobacillus Modifies the Preterm Infant Gut Microbiota and Metabolome: An Observational StudyCristina Alcon-Giner, Matthew J Dalby, Shabhonam Caim, et al.Optics Letters|April 30, 2016
100 J-level nanosecond pulsed diode pumped solid state laserSaumyabrata Banerjee, Paul D Mason, Klaus Ertel, et al.Schizophrenia Research|February 3, 2026
Psychopathology distinguishing secondary ("organic") psychoses: A systematic review and meta-analysisGraham Blackman, Hamilton Morrin, Claire Carstairs, et al.The New England Journal of Medicine|July 2, 2021
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisJulian D Gillmore, Ed Gane, Jorg Taubel, et al.Frontiers in Pharmacology|March 7, 2019
Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate AirwaysKent Miner, Katja Labitzke, Benxian Liu, et al.Journal of Medicinal Chemistry|December 6, 2021
Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1Michael J Boyd, Philip N Collier, Michael P Clark, et al.Pageof 20